Financials
Financials: A High-Margin Niche Leader at a Cyclical Trough
Somero reports its financial statements in US dollars; all figures below are as-reported in USD. The shares trade as Depositary Interests in GBP pence on the AIM market of the London Stock Exchange, so the share price is quoted in pence and converted to USD at the prevailing FX rate only for market-capitalisation and valuation purposes.
Somero designs and builds laser-guided concrete leveling machines — a category it invented in 1986 and still leads, selling into 90-plus countries [11]. For an investor, the financial signature is unusually clean: a debt-free balance sheet, gross margins above 50%, returns on capital that have run from the mid-teens to above 50%, and free cash flow that routinely exceeds net income — wrapped around one hard problem, deep cyclicality. Revenue has fallen for three straight years, from a 2022 peak of US$133.6m to US$88.9m in 2025, a 33% drop, with profit falling considerably faster [9] [1].
The core question this page answers: is this a high-quality, cash-generative compounder priced at a cyclical low — or a structurally challenged small-cap whose trough is the new normal? The numbers lean toward the former, but the swing factor is concentrated in one line: North American demand for large "Boomed" screeds.
The 30-Second Read
FY2025 Revenue ($M)
▼ -18.6% YoY
Adjusted EBITDA ($M)
▲ 19.7% Margin
Free Cash Flow ($M)
▲ 12.0% FCF Yield
Net Cash ($M)
▲ $0.18 Diluted EPS
Sources: revenue, adjusted EBITDA, net cash and EPS per FY2025 Annual Report Highlights and Financial Review [11] [4]; FCF yield derived from reported FCF and AIM market capitalisation.
The judgment in one line: Somero is a genuinely high-quality business — debt-free, 52% gross margin even at trough, 12% free-cash-flow yield, and a 50%-of-earnings dividend — that is mid-cycle in its earnings cycle, not its quality. The risk is not the balance sheet; it is whether North American non-residential construction re-accelerates before the market loses patience.
Three terms recur below. Adjusted EBITDA is the company's preferred profit gauge — net income before tax, interest, FX, depreciation, amortisation, stock compensation and non-cash lease expense — and it is the metric used in its banking covenants and incentive plans [4]. Free cash flow (FCF) is operating cash flow minus capital expenditure — the cash genuinely available to owners. ROCE (return on capital employed) measures operating profit against the capital tied up in the business; for an asset-light manufacturer like Somero, a high ROCE is the signature of a strong franchise.
What Kind of Business the Numbers Describe
Somero is a cyclical niche industrial, not a steady compounder. Revenue tracks private non-residential construction — warehouses, distribution centres, data centres, manufacturing plants — and that demand swings hard. The decade below shows two regimes: a long ~US$80-94m base through 2016-2020, a step-change to a US$133m peak in 2021-2022 as the post-pandemic warehouse and logistics build-out surged, and a three-year normalisation back toward the historical base.
Source: revenue by geography per Annual Report Note 14 and Financial Review disclosures, FY2016-FY2025; FY2025 total US$88.9m [3] and FY2022 record US$133.6m [9].
The key read: the 2021-2022 peak was an exceptional cycle, not a new baseline. Management itself frames 2022's US$133.6m as "an all-time high… that marginally surpassed the extraordinary" 2021 result [9]. FY2025's US$88.9m sits right on the pre-boom base, which reframes the "33% decline" less as deterioration and more as a return to trend after an extraordinary spike. The business mix is concentrated: Boomed screeds (39%) and Ride-on screeds (18%) are the big-ticket machine lines, with the more resilient Parts and Service stream at roughly 19% of revenue [3].
Profit is far more cyclical than revenue because of operating leverage. As volumes fell, operating income compressed from US$43.1m (2022) to US$13.9m (2025) — revenue down 33%, operating profit down 68%.
Source: revenue and operating income per FY2025 Financial Review [4] and FY2022 Financial Review (FY2021-FY2022 operating income US$45.1m / US$43.1m) [10].
The Year-Wise Statements
The full audited statements are only published in USD for the years below; the company's structured multi-year history runs FY2022-FY2025, which captures one complete down-leg of the cycle. Read top to bottom, the table tells a single story — a high-margin franchise giving back the cyclical surplus while its balance sheet barely moves.
Source: Consolidated Statements and Financial Review, FY2022-FY2025 Annual Reports; income statement and per-share data [4], balance sheet [5] and cash flow [6]; ROCE per reported financials.
Two things jump out. First, debt is zero in every year — the entire downturn was absorbed with no balance-sheet stress. Second, equity barely changed (US$77m to US$82m) despite the profit collapse, because Somero pays out most of its earnings and holds little else. This is a business that converts profit to cash and returns it, rather than retaining and reinvesting at scale.
Earnings Quality: Cash Beats Reported Profit
The single best evidence of earnings quality is that free cash flow has matched or exceeded net income in every year of the downturn — and in FY2025 it was 1.7x net income. A business whose accounting profit reliably turns into more cash than it reports is the opposite of an earnings-quality red flag.
Source: Consolidated Statements of Cash Flows, FY2022-FY2025 Annual Reports [6].
The FY2025 gap is instructive. Net income fell to US$10.2m, yet operating cash flow rose to US$17.8m — slightly above the prior year — because lower profit was more than offset by higher advance customer deposits, a favourable impact from new US tax legislation, and lower capex and interim dividend outflows [2]. Capital intensity is minimal: capex was just US$0.8m, under 1% of revenue, against US$2.4m the prior year [2]. The one watch item inside the cash flow is inventory, which rose in FY2025 on new-product stocking and lower sales volumes — a use of cash that should reverse as volumes recover [1].
The Balance Sheet Is a Weapon, Not a Constraint
There is no leverage to analyse — and that is the point. At 31 December 2025 the company held US$33.2m of net cash, no debt, and an entirely undrawn US$25.0m secured revolving credit line maturing in August 2027 [2]. Liquidity is overwhelming: current assets cover current liabilities about five times over, and cash alone is roughly 40% of total assets [5].
Source: Consolidated Balance Sheets, FY2025 Annual Report (cash US$33.2m, inventories US$21.0m, total liabilities US$15.5m, equity US$82.4m, no debt) [5].
The honest critique runs the other way: with goodwill of only US$3.3m, no acquisitions in years, and cash piling up, Somero has arguably been under-using its balance sheet. Management has now acknowledged this, formalising a capital-allocation framework that earmarks leverage of up to 2.0x net debt to EBITDA for value-accretive acquisitions that clear a "ROIC above cost of capital" hurdle — the first real signal that the idle balance sheet may finally be put to work [7]. Until a deal lands, the net cash is best read as a downturn cushion and optionality, not dead weight.
Margins and Returns Through the Cycle
This is where Somero's quality is most visible. Gross margin has held above 50% even as volumes fell by a third — a function of a premium brand and a deliberately flexible, largely variable cost structure that lets the company stay profitable through the cycle [7]. FY2025 gross margin of 52% was down only two points from 54%, despite higher input and logistics costs and unabsorbed overhead, partly offset by price increases [3].
Source: gross margin and adjusted EBITDA margin per FY2024 and FY2025 Financial Reviews (2024 gross 53.9% / 2023 55.8%; 2024 EBITDA margin 25.3% / 2023 30.2%) [8] [3]; operating and net margins per reported financials.
Returns on capital tell the cyclical story most starkly. ROCE peaked above 50% in 2022 and compressed to 16% in 2025 — but 16% at the bottom of the cycle is still a genuinely good return on capital, and it implies mid-cycle returns comfortably in the 25-40% range.
Source: ROCE and ROE derived from reported operating income, capital employed and shareholders' equity, FY2022-FY2025 [4] [5].
How does that quality look against the listed "peer" set? With heavy caveats. The companies screened as comparables — Terex, Astec, Manitou, Wacker Neuson, Zoomlion — are diversified construction-equipment OEMs many times Somero's size (revenue from roughly US$1.4bn to over US$50bn equivalent), not pure-play concrete-leveling specialists. Somero names no true listed peer in its own filings; it positions itself as the category leader it created. That mismatch is exactly why the comparison is revealing: even at its cyclical trough, Somero's margins and returns sit in a different league.
Source: Somero per reported financials [4]; peer margins and ROCE from latest reported FY2025 financials (revenue shown in each company's own reporting currency, not converted).
Somero's 52% gross margin is roughly double the best peer's, and its 16% trough ROCE beats every peer's full-cycle figure. The takeaway is not that Somero is a better business than a US$5bn diversified OEM in every respect — it is far smaller and far more concentrated — but that its niche commands pricing and capital efficiency that mass-market equipment makers cannot match. That premium is the asset an investor is really buying.
Capital Allocation: From Special Dividends to a Formal Framework
Somero's historic model was simple — earn cash, return almost all of it. In the boom years that meant large special dividends on top of the ordinary: total cash returned via dividends ran to US$29.0m in 2022 and US$19.8m in 2023, comfortably above net income in some years. As earnings normalised, the payout was rebased rather than defended at unsustainable levels.
Source: dividends paid and share repurchases per Consolidated Statements of Cash Flows, FY2022-FY2025 Annual Reports [6].
The FY2025 framework puts numbers on the policy: an ordinary dividend at 50% of adjusted net income, buybacks to offset equity-award dilution, and acquisitions as the swing use of cash [7]. The FY2025 ordinary dividend totalled US$0.1024 per share (a final US$0.0624 plus the US$0.0400 interim), down 40% from US$0.1693 in 2024 — a clean read-through of the formula working as earnings fell [1]. The company also repurchased 856,785 shares in 2025 and authorised a fresh buyback of up to US$6.0m for 2026 [1]. Share count is therefore broadly stable — buybacks roughly offset award dilution rather than shrinking the base aggressively.
The capital-allocation verdict: disciplined and shareholder-friendly, with one open question. A rebased-but-secure dividend and modest buybacks are exactly right for a cyclical trough. The unknown is whether the new acquisition mandate adds value or simply spends a pristine balance sheet — the M and A framework is new and unproven, so it belongs in the "watch" column, not the "credit" column.
Valuation: Cheap on Mid-Cycle, Optically Full on Trough
At 193p (19 June 2026), against ~55.4m shares, Somero's market capitalisation is roughly US$142m and its enterprise value about US$108m after stripping out net cash. The multiple you reach depends entirely on which point in the cycle you anchor to.
P/E (FY2025 trough earnings)
EV / Adj EBITDA
Price / Free Cash Flow
Free Cash Flow Yield
Ordinary Dividend Yield
Price / Book
Source: derived from the AIM share price (193p, converted to USD), ~55.4m shares, and reported FY2025 net income, adjusted EBITDA, free cash flow, net cash and equity [4] [5].
The headline P/E of about 14x looks unremarkable until you remember it is 14x trough earnings. Apply the same enterprise value to mid-cycle profitability and the picture changes sharply:
Source: implied multiples computed at the current enterprise value against each year's reported earnings and adjusted EBITDA, FY2022-FY2025 [4] [9].
The cyclical lens is the whole valuation debate. On trough numbers, the stock is fairly priced; on any normalisation toward FY2023-FY2024 earnings, today's price implies 3-4x EV/EBITDA and 5-8x earnings for a debt-free, 50%-gross-margin franchise — demonstrably cheap if the cycle turns. Supporting that view: a ~12% free-cash-flow yield and a ~4% ordinary dividend yield, both well-covered. The single sell-side analyst covering the stock carries a Buy with a 264p target, roughly 37% above the current price — but coverage this thin (one analyst, FY2026 consensus of ~US$86m revenue and US$0.19 EPS) is itself a small-cap risk, not a robust external check.
What the bears get right: there is no margin of safety if the trough is structural. If US warehouse and logistics overbuild has durably reduced demand for large Boomed screeds, or if intensifying European and Chinese competition compresses Somero's premium pricing, then FY2025 is closer to fair value than to a springboard. Management's own FY2026 guidance — revenue, profitability and cash generation "broadly comparable to 2025," with an extra ~US$2.0m of strategic operating cost — explicitly does not promise a recovery next year [2]. Note also that 2025's reported earnings were depressed by a 33% effective tax rate (versus 22% in 2024), inflated by a one-off valuation allowance on foreign deferred tax assets — so trough EPS modestly understates underlying earning power [3].
(Two scoring inputs a reader may expect — a Quality Score and a Fair Value gap — are not available in this run's data set, so the valuation case rests on the multiple-versus-cycle and balance-sheet evidence above rather than a single composite score.)
What the Financials Confirm, and What They Contradict
Confirmed: Somero is a high-quality business by every internal measure that matters — debt-free, 52% gross margins that held through a one-third revenue decline, free cash flow above net income, and returns on capital that stay attractive even at the bottom of the cycle. Capital allocation is disciplined: the dividend flexes with earnings at a stated 50% payout, and the balance sheet has never been at risk.
Contradicted: the bull case is not one of secular growth. Revenue today is back at its pre-2021 base, profit is down nearly 70% from peak, and management guides to no recovery in 2026. Anyone underwriting Somero as a steady compounder is misreading a cyclical. The unproven new acquisition mandate is the one place where this clean capital-allocation record could be damaged.
The investment case therefore turns on a single judgment: is US$88.9m a trough or a ceiling? Everything that makes Somero attractive — the cheap mid-cycle multiple, the 12% FCF yield, the optionality in the net cash — pays off only if demand normalises off the current base.
The first financial metric to watch is North American machine revenue — specifically Boomed-screed sales in North America. It is the largest, highest-margin, most cyclical line (North America was 77% of FY2025 revenue, and Boomed screeds the biggest product category, with North American Boomed screed sales falling to US$26.2m from US$31.4m) [3]. A turn here drops almost directly to gross profit through operating leverage and is the cleanest early read on whether 2025 was the bottom. If that line inflects up over the next two halves, the mid-cycle valuation case is live; if it keeps sliding, the trough is the new base.